Author | Bert H. O’Neil, MD


Liver, Gallbladder, and Biliary Tract Cancers

November 01, 2015

This management guide covers the risk factors, symptoms, diagnosis, staging, and treatment of liver, gallbladder, and biliary tract cancers using radiation, surgery, and medical treatment.

The Role of HIPEC in Gastrointestinal Malignancies: Controversies and Conclusions

July 15, 2015

It is clear that in a subset of patients with GI malignancies, particularly the low-grade appendiceal neoplasms, CS + HIPEC can result in improved outcomes and in some cases, long-term remission and occasionally cure.

Colorectal Cancer and Molecular Targeted Agents: Progress-With Caveats

February 15, 2014

Progress in the area of targeted therapies for colorectal cancer has come slowly and with some difficulty.

Cancer Management Chapter 12: Liver, gallbladder, and biliary tract cancers

March 10, 2010

Worldwide, hepatocellular carcinoma is the fifth most common malignancy and the third most common cause of cancer mortality. Most patients with hepatocellular carcinoma suffer from cirrhosis primarily caused by alcoholism or chronic infection with hepatitis B virus (HBV) or hepatitis C virus (HCV); decades may pass between infection with viral hepatitis and development of this cancer. The approximately equal annual incidence and mortality of 1 million reported around the world stands as evidence of its lethality.